About Propharmex
Propharmex is a Healthcare company based in Hyderabad (India) founded in 2017. It serves as a CDMO specializing in manufacturing capsules, tablets, suspensions, injections, and topical semi-solids. It operates on a B2B model. The company has 10 employees. Its Indian entity Propharmex India Private Limited reported revenue of ₹2.84 Cr. Its focus areas include Pharmaceuticals, Manufacturing and CDMO Services. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Propharmex, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Serves as a CDMO specializing in manufacturing capsules, tablets, suspensions, injections, and topical semi-solids. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Hyderabad, India
- Employees 10
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website propharmex.com
- Legal Name Propharmex India Private Limited
- Date of Incorporation 18 Jan, 2017
- Jurisdiction Nacharam, Telangana, India
- Annual Revenue₹2.84 Cr
FY 2025 · -8% YoY
- Net Profit₹25.3 Lakh
FY 2025 · 9% margin
- EBITDA₹38.7 Lakh
FY 2025 · 14% margin
- Employee Count10
Associated legal entities of Propharmex
Propharmex operates through Propharmex India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Propharmex India Private Limited CIN U74999TG2017PTC114115 | Active | 18 Jan 2017 | Nacharam, Telangana | ₹2.8 Cr | 10 | 3 | View details |
Board of directors of Propharmex India Private Limited (Propharmex)
Propharmex India Private Limited is the primary company behind Propharmex. The board of Propharmex India Private Limited currently have 3 directors; the longest-serving is Prasanna Kumar Shyamsunder Tiruchirapally, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prasanna Kumar Shyamsunder Tiruchirapally DIN 07676640 | Director | 18 Jan 2017 | 9 yrs 9 mo | Propharmex India Private Limited |
| Kuditipudi Krishna Kishore DIN 07693743 | Director | 18 Jan 2017 | 9 yrs 9 mo | Propharmex India Private Limited |
| Musiboina Vijay Kumar DIN 11075832 | Additional Director | 12 May 2025 | 1 yr 5 mo | Propharmex India Private Limited |
Financials of Propharmex
Figures of Propharmex India Private Limited, the primary company behind Propharmex, for FY 2025. Revenue was ₹2.84 Cr (-8% year on year). Net profit was ₹25.3 Lakh (9% margin). EBITDA was ₹38.7 Lakh (14% margin). Revenue has grown at a compounded annual rate of +18% over three years and +24% over five years.
- ₹2.84 CrRevenue · FY 2025 · -8% YoY
- ₹25.3 LakhNet profit · 9% margin
- ₹38.7 LakhEBITDA · 14% margin
- ₹10 LakhPaid-up capital
- 10Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Propharmex India Private Limited are on its company page.
Detailed financial statements for Propharmex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Propharmex
Propharmex has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Propharmex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Propharmex
Propharmex was founded in 2017.
Propharmex is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Propharmex has 10 employees.
The primary company behind Propharmex, Propharmex India Private Limited, reported revenue of ₹2.84 Cr for FY 2025, down 8% year on year.
Propharmex, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Serves as a CDMO specializing in manufacturing capsules, tablets, suspensions, injections, and topical semi-solids. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Propharmex's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Propharmex operates through Propharmex India Private Limited.
The legal entities of Propharmex currently have 3 directors, including Prasanna Kumar Shyamsunder Tiruchirapally, Kuditipudi Krishna Kishore, Musiboina Vijay Kumar.